Hint mode is switched on Switch off
For swift navigation between sections

Taizhou Huaxin Pharmaceutical Investment
LEI 300300FR0GTXUWOLIP71

Organization name
Taizhou Huaxin Pharmaceutical Investment Co.,Ltd.
Country name
China
Country of registration
China
Industry
Wholesale Trade
Credit Ratings
in foreign currency
  • M/S&P/F
    *** / *** / ***
Public debt
1,644 mln USD
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Taizhou Huaxin Pharmaceutical Investment Co., Ltd. offer pharmaceutical drug wholesale and distribution. It also offers land development; and equipment and building leasing services.

Awards

Documentation

IFRS/US GAAP reports

2020
Authorization required
You need to request access

Stocks

Latest issues

Public debt by currencies

Codes

  • LEI
    300300FR0GTXUWOLIP71
  • SIC
    5122 WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
  • NACE
    *** ***
  • NAICS
    *** ***
Registration is required to get access.